RJA
ALAB icon

Raymond James & Associates’s Astera Labs ALAB Stock Holding History

Raymond James & Associates’s Portfolio ALAB Stock Details ALAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$1.75M Buy
+33,344
New +$1.56M ﹤0.01% 2305

Other funds holding ALAB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AM
Atreides Management Boston, Massachusetts $5B AUM 78.34% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
IC
Intel Corp Santa Clara, California $470M AUM 21.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $3.72B AUM 162.29% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Raymond James & Associates's ALAB Position: Q3 2024 in Review

Raymond James & Associates opened a new position in Astera Labs (ALAB) in Q3 2024: 33,344 shares worth $1.75M. The stake represents ﹤0.01% of the portfolio and ranks #2305 among its holdings.

244 funds tracked by Wall St. Rank hold ALAB as of Q3 2024.

  • Raymond James & Associates held 33,344 shares of Astera Labs worth $1.75M as of Q3 2024.
  • Astera Labs was a new Raymond James & Associates position in Q3 2024.
  • Astera Labs made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #2305 holding.
  • 244 funds tracked by Wall St. Rank held Astera Labs as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.